Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:

Recent Articles in IPO/Stock Watch

Laekna Raises $100 Million in Hong Kong IPO for Cancer, Liver Fibrosis Inhibitors
Edding Group Files for Hong Kong IPO to Support its China In-licensing Operations
Cutia Therapeutics Raises $65 Million in Hong Kong IPO for Dermatology Products
HighTide Plans Hong Kong IPO to Support Metabolic and Digestive Portfolio
Apollomics Merges with SPAC to List on NASDAQ; Climbs 121% Higher in Trading
ChinaBio Event
September 20-21 | Shanghai
September 25-26 | Digital
ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes

Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China